Literature DB >> 17377087

Hypercapnia shortens emergence time from inhaled anesthesia in pigs.

Nishant A Gopalakrishnan1, Derek J Sakata, Joseph A Orr, Scott McJames, Dwayne R Westenskow.   

Abstract

BACKGROUND: Anesthetic clearance from the lungs and the circle rebreathing system can be maximized using hyperventilation and high fresh gas flows. However, the concomitant clearance of CO2 decreases PAco2, thereby decreasing cerebral blood flow and slowing the clearance of anesthetic from the brain. This study shows that in addition to hyperventilation, hypercapnia (CO2 infusion or rebreathing) is a significant factor in decreasing emergence time from inhaled anesthesia.
METHODS: We anesthetized seven pigs with 2 MACPIG of isoflurane and four with 2 MACPIG of sevoflurane. After 2 h, anesthesia was discontinued, and the animals were hyperventilated. The time to movement of multiple limbs was measured under hypocapnic (end-tidal CO2 = 22 mm Hg) and hypercapnic (end-tidal CO2 = 55 mm Hg) conditions.
RESULTS: The time between turning off the vaporizer and to movement of multiple limbs was faster with hypercapnia during hyperventilation. Emergence time from isoflurane and sevoflurane anesthesia was shortened by an average of 65% with rebreathing or with the use of a CO2 controller (P < 0.05).
CONCLUSIONS: Hypercapnia, along with hyperventilation, may be used clinically to decrease emergence time from inhaled anesthesia. These time savings might reduce drug costs. In addition, higher PAco2 during emergence may enhance respiratory drive and airway protection after tracheal extubation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377087     DOI: 10.1213/01.ane.0000255199.43961.87

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  Escape From Oblivion: Neural Mechanisms of Emergence From General Anesthesia.

Authors:  Max B Kelz; Paul S García; George A Mashour; Ken Solt
Journal:  Anesth Analg       Date:  2019-04       Impact factor: 5.108

2.  Mild hypercapnia with hyperventilation attenuates recovery from anesthesia in elderly patients.

Authors:  Kishiko Nakai; Hitoshi Yoshida; Hiroshi Hashimoto; Tetsuya Kushikata; Futoshi Kimura; Masatou Kitayama; Hironori Ishihara; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2013-04-24       Impact factor: 2.078

3.  Effect of Acute Hypercapnia on Outcomes and Predictive Risk Factors for Complications among Patients Receiving Bronchoscopic Interventions under General Anesthesia.

Authors:  Qinghao Cheng; Jieli Zhang; Hongwu Wang; Rujin Zhang; Yun Yue; Lei Li
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

4.  Effects of intra-operative end-tidal carbon dioxide levels on the rates of post-operative complications in adults undergoing general anesthesia for percutaneous nephrolithotomy: A clinical trial.

Authors:  Mahmoud Saghaei; Gholamreza Matin; Mohammad Golparvar
Journal:  Adv Biomed Res       Date:  2014-02-28

5.  Theoretical effect of hyperventilation on speed of recovery and risk of rehypnotization following recovery - a GasMan® simulation.

Authors:  Andre M De Wolf; Tom C Van Zundert; Sofie De Cooman; Jan F Hendrickx
Journal:  BMC Anesthesiol       Date:  2012-09-18       Impact factor: 2.217

6.  Hypercapnic hyperventilation shortens emergence time from Propofol and Isoflurane anesthesia.

Authors:  Ahmad Yaraghi; Mohammad Golparvar; Reihanak Talakoub; Hossein Sateie; Ali Mehrabi
Journal:  J Res Pharm Pract       Date:  2013-01

7.  Factors affecting extubation time following pediatric ambulatory surgery: an analysis using electronic anesthesia records from an academic university hospital.

Authors:  Akihiro Kanaya; Norifumi Kuratani; Yoshinori Nakata; Masanori Yamauchi
Journal:  JA Clin Rep       Date:  2017-07-26

8.  Hypercapnia does not shorten emergence time from propofol anesthesia: a pilot randomized clinical study.

Authors:  Ki-Hyug Kwon; Hansu Bae; Hyun Gu Kang; Junyong In
Journal:  Korean J Anesthesiol       Date:  2018-04-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.